Release Date: 12/04/12 17:16 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 50.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%